PDS Biotechnology Corp (PDSB)
3.25
+0.02
(+0.46%)
USD |
NASDAQ |
Nov 05, 16:00
3.25
0.00 (0.00%)
After-Hours: 18:32
PDS Biotechnology Total Liabilities (Quarterly): 29.58M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 29.58M |
| March 31, 2024 | 31.82M |
| December 31, 2023 | 33.26M |
| September 30, 2023 | 32.70M |
| June 30, 2023 | 31.31M |
| March 31, 2023 | 27.44M |
| December 31, 2022 | 33.01M |
| September 30, 2022 | 27.83M |
| June 30, 2022 | 4.576M |
| March 31, 2022 | 5.166M |
| December 31, 2021 | 3.988M |
| September 30, 2021 | 3.891M |
| June 30, 2021 | 4.398M |
| March 31, 2021 | 3.387M |
| December 31, 2020 | 3.761M |
| September 30, 2020 | 3.420M |
| June 30, 2020 | 3.079M |
| March 31, 2020 | 4.047M |
| December 31, 2019 | 2.794M |
| Date | Value |
|---|---|
| September 30, 2019 | 3.801M |
| June 30, 2019 | 5.199M |
| March 31, 2019 | 6.598M |
| December 31, 2018 | 6.382M |
| September 30, 2018 | 6.688M |
| June 30, 2018 | 13.87M |
| March 31, 2018 | 32.33M |
| December 31, 2017 | 30.25M |
| September 30, 2017 | 26.59M |
| June 30, 2017 | 28.72M |
| March 31, 2017 | 21.25M |
| December 31, 2016 | 21.64M |
| September 30, 2016 | 19.07M |
| June 30, 2016 | 8.664M |
| March 31, 2016 | 9.043M |
| December 31, 2015 | 11.62M |
| September 30, 2015 | 109.13M |
| June 30, 2015 | 10.55M |
| December 31, 2014 | 44.68M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.794M
Minimum
Dec 2019
33.26M
Maximum
Dec 2023
15.23M
Average
4.576M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| Chimerix Inc | 22.93M |
| Cellectar Biosciences Inc | 17.00M |
| Marinus Pharmaceuticals Inc | 134.43M |
| Jaguar Health Inc | 44.88M |
| Seres Therapeutics Inc | 408.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 60.50M |
| Shareholders Equity (Quarterly) | 30.92M |